Skip to main content

Table 2 Comparison of treatment parameters and morphine usage between groups

From: Pain control for patients with hepatocellular carcinoma undergoing CT-guided percutaneous microwave ablation

Treatment parameters and Morphine usage

Control Group

Experimental Group

p-value

n = 50

n = 50

 

Ablation duration, mean ± SD

5.33 ± 0.62

5.41 ± 1.04

0.751

Ablation probes

  

< 0.001

 50 W

50 (100.00)

28 (56.00)

 

 60 W

0 (0.00)

21 (42.00)

 

 70 W

0 (0.00)

1 (2.00)

 

Dose level of morphine in the first administration, experimental group,

(mg), mean ± SD

6.84 ± 1.01a

Number of patients needed additional morphine during surgery

24(48.00)

3 (6.67)

< 0.001

Total amount of morphine used (mg)

17.40 ± 2.52

7.18 ± 1.65a

< 0.001

Number of patients with surgery terminated

3 (6.00)

0 (0.00)

0.242

  1. aMorphine was given to 45 patients in the Experimental group who reported VAS ≥ 4, and 5 patients had no morphine administrated during the whole procedure